Calithera Biosciences, Inc. CALA was a big mover last session, as the company saw its shares rise almost 8% on the day. The news led to far more shares changing hands than in a normal session, resulting in solid volume. This continues the recent downtrend for the company as the stock is now below 32.4% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Calithera Biosciences has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Another better-ranked stock in the Medicinal Drugs industry is Bio Blast Pharma Ltd. ORPN sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment